{
    "Trade/Device Name(s)": [
        "SmartAdjust technology",
        "Omnipod 5 iAGC"
    ],
    "Submitter Information": "Insulet Corporation",
    "510(k) Number": "K203774",
    "Predicate Device Reference 510(k) Number(s)": [
        "K200467"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "QJI"
    ],
    "Summary Letter Date": "January 27, 2022",
    "Summary Letter Received Date": "September 3, 2021",
    "Submission Date": "September 2, 2021",
    "Regulation Number(s)": [
        "21 CFR 862.1356"
    ],
    "Regulation Name(s)": [
        "Interoperable Automated Glycemic Controller"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "endocrine",
        "POCT"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Omnipod 5 ACE Pump",
        "Omnipod 5 Pod",
        "Omnipod 5 App",
        "interoperable iCGM",
        "compatible ACE Pump"
    ],
    "Method(s)/Technology(ies)": [
        "Algorithmic insulin delivery",
        "Continuous glucose monitoring",
        "Bluetooth Low Energy (BLE)"
    ],
    "Methodologies": [
        "Automated glycemic control",
        "Closed-loop insulin delivery",
        "Software algorithm"
    ],
    "Submission Type(s)": [
        "Software",
        "Component"
    ],
    "Document Summary": "FDA 510(k) summary for Omnipod 5 iAGC (SmartAdjust technology) interoperable automated glycemic controller software for insulin delivery based on iCGM data",
    "Indications for Use Summary": "Intended for use with compatible integrated continuous glucose monitors and ACE pumps to automatically increase, decrease, and pause delivery of insulin based on current and predicted glucose values for management of type 1 diabetes mellitus in persons 6 years and older.",
    "fda_folder": "Clinical Chemistry"
}